Monsanto Company (NYSE:MON) has been upgraded from Sell to Neutral in a report by Goldman Sachs today.
- Updated: September 27, 2016
Just yesterday Monsanto Company (NYSE:MON) traded 0.32% higher at $102.37. MON’s 50-day average is $105.60 and its two hundred day average is $100.83. The last stock close price is up 1.62% relative to the two hundred day average, compared with the S&P 500 Index which has decreased -0.01% over the same period. Trade Volume was down over the average, with 1,514,794 shares of MON changing hands under the typical 4,225,250
Goldman Sachs has upgraded Monsanto Company (NYSE:MON) from Sell to Neutral in a report released on 09/27/2016.
Recent Performance Chart
Monsanto Company has PE ratio of 45.10 with a one year low of $82.97 and a one year high of $114.26 and has a market capitalization of $0.
A total of 19 analysts have released a report on Monsanto Company. Three brokerages rating the stock a strong buy, 10 analysts rating the company a buy, 8 equity analysts rating the company a hold, 2 firms rating the stock a underperform, and finally one analyst rating the company a sell with a average stock price target of $98.37.
Brief Synopsis On Monsanto Company (NYSE:MON)
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity. Through its Seeds and Genomics segment, the Company produces seed brands, including DEKALB, Asgrow, Deltapine, Seminis and De Ruiter, and it develops biotechnology traits that assist farmers in controlling insects and weeds and precision agriculture to assist farmers in decision-making. It offers products, such as Germplasm and Biotechnology traits. Through its Agricultural Productivity segment, the Company manufactures Roundup brand herbicides and other herbicides and provides lawn-and-garden herbicide products for the residential market.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.